<?xml version="1.0" encoding="UTF-8" standalone="no"?><document id="DrugDDI.d270" origId="Efavirenz"><sentence id="DrugDDI.d270.s0" origId="s0" text="Efavirenz has been shown in vivo to induce CYP3A4."><entity charOffset="0-9" id="DrugDDI.d270.s0.e0" origId="s0.p0" text="Efavirenz" type="drug"/><entity charOffset="43-49" id="DrugDDI.d270.s0.e1" origId="s0.p6" text="CYP3A4" type="drug"/><pair e1="DrugDDI.d270.s0.e0" e2="DrugDDI.d270.s0.e1" id="DrugDDI.d270.s0.p0" interaction="true"/></sentence><sentence id="DrugDDI.d270.s1" origId="s1" text="Other compounds that are substrates of CYP3A4 may have decreased plasma concentrations when coadministered with SUSTIVA (efavirenz)."><entity charOffset="39-45" id="DrugDDI.d270.s1.e0" origId="s1.p11" text="CYP3A4" type="drug"/><entity charOffset="112-119" id="DrugDDI.d270.s1.e1" origId="s1.p17" text="SUSTIVA" type="drug"/><entity charOffset="121-130" id="DrugDDI.d270.s1.e2" origId="s1.p19" text="efavirenz" type="drug"/><pair e1="DrugDDI.d270.s1.e0" e2="DrugDDI.d270.s1.e1" id="DrugDDI.d270.s1.p0" interaction="false"/><pair e1="DrugDDI.d270.s1.e0" e2="DrugDDI.d270.s1.e2" id="DrugDDI.d270.s1.p1" interaction="false"/><pair e1="DrugDDI.d270.s1.e1" e2="DrugDDI.d270.s1.e2" id="DrugDDI.d270.s1.p2" interaction="false"/></sentence><sentence id="DrugDDI.d270.s2" origId="s2" text="In vitro studies have demonstrated that efavirenz inhibits 2C9, 2C19, and 3A4 isozymes in the range of observed efavirenz plasma concentrations."><entity charOffset="40-49" id="DrugDDI.d270.s2.e0" origId="s2.p24" text="efavirenz" type="drug"/><entity charOffset="78-86" id="DrugDDI.d270.s2.e1" origId="s2.p29" text="isozymes" type="drug"/><entity charOffset="112-121" id="DrugDDI.d270.s2.e2" origId="s2.p31" text="efavirenz" type="drug"/><pair e1="DrugDDI.d270.s2.e0" e2="DrugDDI.d270.s2.e1" id="DrugDDI.d270.s2.p0" interaction="true"/><pair e1="DrugDDI.d270.s2.e0" e2="DrugDDI.d270.s2.e2" id="DrugDDI.d270.s2.p1" interaction="false"/><pair e1="DrugDDI.d270.s2.e1" e2="DrugDDI.d270.s2.e2" id="DrugDDI.d270.s2.p2" interaction="false"/></sentence><sentence id="DrugDDI.d270.s3" origId="s3" text="Coadministration of efavirenz with drugs primarily metabolized by these isozymes may result in altered plasma concentrations of the coadministered drug."><entity charOffset="20-29" id="DrugDDI.d270.s3.e0" origId="s3.p33" text="efavirenz" type="drug"/><entity charOffset="35-40" id="DrugDDI.d270.s3.e1" origId="s3.p34" text="drugs" type="drug"/><entity charOffset="72-80" id="DrugDDI.d270.s3.e2" origId="s3.p36" text="isozymes" type="drug"/><entity charOffset="147-151" id="DrugDDI.d270.s3.e3" origId="s3.p40" text="drug" type="drug"/><pair e1="DrugDDI.d270.s3.e0" e2="DrugDDI.d270.s3.e1" id="DrugDDI.d270.s3.p0" interaction="true"/><pair e1="DrugDDI.d270.s3.e0" e2="DrugDDI.d270.s3.e2" id="DrugDDI.d270.s3.p1" interaction="false"/><pair e1="DrugDDI.d270.s3.e0" e2="DrugDDI.d270.s3.e3" id="DrugDDI.d270.s3.p2" interaction="false"/><pair e1="DrugDDI.d270.s3.e1" e2="DrugDDI.d270.s3.e2" id="DrugDDI.d270.s3.p3" interaction="false"/><pair e1="DrugDDI.d270.s3.e1" e2="DrugDDI.d270.s3.e3" id="DrugDDI.d270.s3.p4" interaction="false"/><pair e1="DrugDDI.d270.s3.e2" e2="DrugDDI.d270.s3.e3" id="DrugDDI.d270.s3.p5" interaction="false"/></sentence><sentence id="DrugDDI.d270.s4" origId="s4" text="Therefore, appropriate dose adjustments may be necessary for these drugs."><entity charOffset="67-72" id="DrugDDI.d270.s4.e0" origId="s4.p46" text="drugs" type="drug"/></sentence><sentence id="DrugDDI.d270.s5" origId="s5" text="Drugs which induce CYP3A4 activity (eg, phenobarbital, rifampin, rifabutin) would be expected to increase the clearance of efavirenz resulting in lowered plasma concentrations."><entity charOffset="0-5" id="DrugDDI.d270.s5.e0" origId="s5.p47" text="Drugs" type="drug"/><entity charOffset="19-25" id="DrugDDI.d270.s5.e1" origId="s5.p50" text="CYP3A4" type="drug"/><entity charOffset="40-53" id="DrugDDI.d270.s5.e2" origId="s5.p53" text="phenobarbital" type="drug"/><entity charOffset="55-63" id="DrugDDI.d270.s5.e3" origId="s5.p54" text="rifampin" type="drug"/><entity charOffset="65-74" id="DrugDDI.d270.s5.e4" origId="s5.p55" text="rifabutin" type="drug"/><entity charOffset="123-132" id="DrugDDI.d270.s5.e5" origId="s5.p63" text="efavirenz" type="drug"/><pair e1="DrugDDI.d270.s5.e0" e2="DrugDDI.d270.s5.e1" id="DrugDDI.d270.s5.p0" interaction="false"/><pair e1="DrugDDI.d270.s5.e0" e2="DrugDDI.d270.s5.e2" id="DrugDDI.d270.s5.p1" interaction="false"/><pair e1="DrugDDI.d270.s5.e0" e2="DrugDDI.d270.s5.e3" id="DrugDDI.d270.s5.p2" interaction="false"/><pair e1="DrugDDI.d270.s5.e0" e2="DrugDDI.d270.s5.e4" id="DrugDDI.d270.s5.p3" interaction="false"/><pair e1="DrugDDI.d270.s5.e0" e2="DrugDDI.d270.s5.e5" id="DrugDDI.d270.s5.p4" interaction="true"/><pair e1="DrugDDI.d270.s5.e1" e2="DrugDDI.d270.s5.e2" id="DrugDDI.d270.s5.p5" interaction="false"/><pair e1="DrugDDI.d270.s5.e1" e2="DrugDDI.d270.s5.e3" id="DrugDDI.d270.s5.p6" interaction="false"/><pair e1="DrugDDI.d270.s5.e1" e2="DrugDDI.d270.s5.e4" id="DrugDDI.d270.s5.p7" interaction="false"/><pair e1="DrugDDI.d270.s5.e1" e2="DrugDDI.d270.s5.e5" id="DrugDDI.d270.s5.p8" interaction="false"/><pair e1="DrugDDI.d270.s5.e2" e2="DrugDDI.d270.s5.e3" id="DrugDDI.d270.s5.p9" interaction="false"/><pair e1="DrugDDI.d270.s5.e2" e2="DrugDDI.d270.s5.e4" id="DrugDDI.d270.s5.p10" interaction="false"/><pair e1="DrugDDI.d270.s5.e2" e2="DrugDDI.d270.s5.e5" id="DrugDDI.d270.s5.p11" interaction="true"/><pair e1="DrugDDI.d270.s5.e3" e2="DrugDDI.d270.s5.e4" id="DrugDDI.d270.s5.p12" interaction="false"/><pair e1="DrugDDI.d270.s5.e3" e2="DrugDDI.d270.s5.e5" id="DrugDDI.d270.s5.p13" interaction="true"/><pair e1="DrugDDI.d270.s5.e4" e2="DrugDDI.d270.s5.e5" id="DrugDDI.d270.s5.p14" interaction="true"/></sentence><sentence id="DrugDDI.d270.s6" origId="s6" text="Drug interactions with SUSTIVA are summarized in Table 5."><entity charOffset="23-30" id="DrugDDI.d270.s6.e0" origId="s6.p67" text="SUSTIVA" type="drug"/></sentence><sentence id="DrugDDI.d270.s7" origId="s7" text="Table 5a: Drugs That Should Not Be Coadministered With SUSTIVA"><entity charOffset="10-15" id="DrugDDI.d270.s7.e0" origId="s7.p73" text="Drugs" type="drug"/><entity charOffset="55-62" id="DrugDDI.d270.s7.e1" origId="s7.p79" text="SUSTIVA" type="drug"/><pair e1="DrugDDI.d270.s7.e0" e2="DrugDDI.d270.s7.e1" id="DrugDDI.d270.s7.p0" interaction="true"/></sentence><sentence id="DrugDDI.d270.s8" origId="s8" text="Drug Class"><entity charOffset="0-4" id="DrugDDI.d270.s8.e0" origId="s8.p80" text="Drug" type="drug"/></sentence><sentence id="DrugDDI.d270.s9" origId="s9" text="Drugs Within Class Not To Be Coadministered With SUSTIVA"><entity charOffset="0-5" id="DrugDDI.d270.s9.e0" origId="s9.p81" text="Drugs" type="drug"/><entity charOffset="49-56" id="DrugDDI.d270.s9.e1" origId="s9.p86" text="SUSTIVA" type="drug"/><pair e1="DrugDDI.d270.s9.e0" e2="DrugDDI.d270.s9.e1" id="DrugDDI.d270.s9.p0" interaction="false"/></sentence><sentence id="DrugDDI.d270.s10" origId="s10" text="Antihistamines Benzodiazepines GI Motility Agents Anti-Migraine Antifungal"><entity charOffset="0-14" id="DrugDDI.d270.s10.e0" origId="s10.p87" text="Antihistamines" type="drug"/></sentence><sentence id="DrugDDI.d270.s11" origId="s11" text="astemizole midazolam, triazolam cisapride ergot derivatives voriconazole"><entity charOffset="0-10" id="DrugDDI.d270.s11.e0" origId="s11.p88" text="astemizole" type="drug"/><entity charOffset="22-31" id="DrugDDI.d270.s11.e1" origId="s11.p89" text="triazolam" type="drug"/><entity charOffset="60-72" id="DrugDDI.d270.s11.e2" origId="s11.p90" text="voriconazole" type="drug"/><pair e1="DrugDDI.d270.s11.e0" e2="DrugDDI.d270.s11.e1" id="DrugDDI.d270.s11.p0" interaction="false"/><pair e1="DrugDDI.d270.s11.e0" e2="DrugDDI.d270.s11.e2" id="DrugDDI.d270.s11.p1" interaction="false"/><pair e1="DrugDDI.d270.s11.e1" e2="DrugDDI.d270.s11.e2" id="DrugDDI.d270.s11.p2" interaction="false"/></sentence><sentence id="DrugDDI.d270.s12" origId="s12" text="Established Drug Interactions"/><sentence id="DrugDDI.d270.s13" origId="s13" text="?"/><sentence id="DrugDDI.d270.s14" origId="s14" text="Drug Name"><entity charOffset="0-4" id="DrugDDI.d270.s14.e0" origId="s14.p93" text="Drug" type="drug"/></sentence><sentence id="DrugDDI.d270.s15" origId="s15" text="Effect"/><sentence id="DrugDDI.d270.s16" origId="s16" text="Clinical Comment"/><sentence id="DrugDDI.d270.s17" origId="s17" text="Atazanavir"><entity charOffset="0-10" id="DrugDDI.d270.s17.e0" origId="s17.p96" text="Atazanavir" type="drug"/></sentence><sentence id="DrugDDI.d270.s18" origId="s18" text="?atazanavir"/><sentence id="DrugDDI.d270.s19" origId="s19" text="When coadministered with SUSTIVA in treatment-naive patients, the recommended dose of atazanavir is 300 mg with ritonavir 100 mg and SUSTIVA 600 mg (all once daily)."><entity charOffset="25-32" id="DrugDDI.d270.s19.e0" origId="s19.p100" text="SUSTIVA" type="drug"/><entity charOffset="86-96" id="DrugDDI.d270.s19.e1" origId="s19.p103" text="atazanavir" type="drug"/><entity charOffset="112-128" id="DrugDDI.d270.s19.e2" origId="s19.p106" text="ritonavir 100 mg" type="drug"/><entity charOffset="133-140" id="DrugDDI.d270.s19.e3" origId="s19.p108" text="SUSTIVA" type="drug"/><pair e1="DrugDDI.d270.s19.e0" e2="DrugDDI.d270.s19.e1" id="DrugDDI.d270.s19.p0" interaction="false"/><pair e1="DrugDDI.d270.s19.e0" e2="DrugDDI.d270.s19.e2" id="DrugDDI.d270.s19.p1" interaction="false"/><pair e1="DrugDDI.d270.s19.e0" e2="DrugDDI.d270.s19.e3" id="DrugDDI.d270.s19.p2" interaction="false"/><pair e1="DrugDDI.d270.s19.e1" e2="DrugDDI.d270.s19.e2" id="DrugDDI.d270.s19.p3" interaction="false"/><pair e1="DrugDDI.d270.s19.e1" e2="DrugDDI.d270.s19.e3" id="DrugDDI.d270.s19.p4" interaction="false"/><pair e1="DrugDDI.d270.s19.e2" e2="DrugDDI.d270.s19.e3" id="DrugDDI.d270.s19.p5" interaction="false"/></sentence><sentence id="DrugDDI.d270.s20" origId="s20" text="Dosing recommendations for SUSTIVA and atazanavir in treatment-experienced patients have not been established."><entity charOffset="27-34" id="DrugDDI.d270.s20.e0" origId="s20.p114" text="SUSTIVA" type="drug"/><entity charOffset="39-49" id="DrugDDI.d270.s20.e1" origId="s20.p116" text="atazanavir" type="drug"/><pair e1="DrugDDI.d270.s20.e0" e2="DrugDDI.d270.s20.e1" id="DrugDDI.d270.s20.p0" interaction="false"/><negationtags>&lt;xcope&gt;Dosing recommendations for SUSTIVA and atazanavir in treatment-experienced patients have &lt;cue&gt;not&lt;/cue&gt; been established&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d270.s21" origId="s21" text="Established Drug Interactions (continued)"/><sentence id="DrugDDI.d270.s22" origId="s22" text="Drug Name"><entity charOffset="0-4" id="DrugDDI.d270.s22.e0" origId="s22.p126" text="Drug" type="drug"/></sentence><sentence id="DrugDDI.d270.s23" origId="s23" text="Effect"/><sentence id="DrugDDI.d270.s24" origId="s24" text="Clinical Comment"/><sentence id="DrugDDI.d270.s25" origId="s25" text="Clarithromycin"><entity charOffset="0-14" id="DrugDDI.d270.s25.e0" origId="s25.p129" text="Clarithromycin" type="drug"/></sentence><sentence id="DrugDDI.d270.s26" origId="s26" text="??clarithromycin concentration"><entity charOffset="2-16" id="DrugDDI.d270.s26.e0" origId="s26.p131" text="clarithromycin" type="drug"/></sentence><sentence id="DrugDDI.d270.s27" origId="s27" text="Plasma concentrations decreased by SUSTIVA;"><entity charOffset="35-42" id="DrugDDI.d270.s27.e0" origId="s27.p134" text="SUSTIVA" type="drug"/></sentence><sentence id="DrugDDI.d270.s28" origId="s28" text="clinical significance unknown."/><sentence id="DrugDDI.d270.s29" origId="s29" text="In uninfected volunteers, 46% developed rash while receiving SUSTIVA and clarithromycin."><entity charOffset="61-68" id="DrugDDI.d270.s29.e0" origId="s29.p141" text="SUSTIVA" type="drug"/><entity charOffset="73-87" id="DrugDDI.d270.s29.e1" origId="s29.p143" text="clarithromycin" type="drug"/><pair e1="DrugDDI.d270.s29.e0" e2="DrugDDI.d270.s29.e1" id="DrugDDI.d270.s29.p0" interaction="true"/></sentence><sentence id="DrugDDI.d270.s30" origId="s30" text="No dose adjustment of SUSTIVA is recommended when given with clarithromycin."><entity charOffset="22-29" id="DrugDDI.d270.s30.e0" origId="s30.p145" text="SUSTIVA" type="drug"/><entity charOffset="61-75" id="DrugDDI.d270.s30.e1" origId="s30.p150" text="clarithromycin" type="drug"/><pair e1="DrugDDI.d270.s30.e0" e2="DrugDDI.d270.s30.e1" id="DrugDDI.d270.s30.p0" interaction="false"/><negationtags>&lt;xcope&gt;&lt;cue&gt;No&lt;/cue&gt; dose adjustment of SUSTIVA is recommended &lt;/xcope&gt; when given with clarithromycin.</negationtags></sentence><sentence id="DrugDDI.d270.s31" origId="s31" text="Alternatives to clarithromycin, such as azithromycin, should be considered."><entity charOffset="16-30" id="DrugDDI.d270.s31.e0" origId="s31.p152" text="clarithromycin" type="drug"/><entity charOffset="40-52" id="DrugDDI.d270.s31.e1" origId="s31.p153" text="azithromycin" type="drug"/><pair e1="DrugDDI.d270.s31.e0" e2="DrugDDI.d270.s31.e1" id="DrugDDI.d270.s31.p0" interaction="false"/></sentence><sentence id="DrugDDI.d270.s32" origId="s32" text="Other macrolide antibiotics, such as erythromycin, have not been studied in combination with SUSTIVA."><entity charOffset="6-27" id="DrugDDI.d270.s32.e0" origId="s32.p157" text="macrolide antibiotics" type="drug"/><entity charOffset="37-49" id="DrugDDI.d270.s32.e1" origId="s32.p158" text="erythromycin" type="drug"/><entity charOffset="93-100" id="DrugDDI.d270.s32.e2" origId="s32.p164" text="SUSTIVA" type="drug"/><pair e1="DrugDDI.d270.s32.e0" e2="DrugDDI.d270.s32.e1" id="DrugDDI.d270.s32.p0" interaction="false"/><pair e1="DrugDDI.d270.s32.e0" e2="DrugDDI.d270.s32.e2" id="DrugDDI.d270.s32.p1" interaction="false"/><pair e1="DrugDDI.d270.s32.e1" e2="DrugDDI.d270.s32.e2" id="DrugDDI.d270.s32.p2" interaction="false"/><negationtags>&lt;xcope&gt; Other macrolide antibiotics, such as erythromycin, have &lt;cue&gt;not&lt;/cue&gt; been studied&lt;/xcope&gt; in combination with SUSTIVA.</negationtags></sentence><sentence id="DrugDDI.d270.s33" origId="s33" text="??"/><sentence id="DrugDDI.d270.s34" origId="s34" text="14-OH metabolite concentration"/><sentence id="DrugDDI.d270.s35" origId="s35" text="Indinavir"><entity charOffset="0-9" id="DrugDDI.d270.s35.e0" origId="s35.p167" text="Indinavir" type="drug"/></sentence><sentence id="DrugDDI.d270.s36" origId="s36" text="??indinavir concentration"><entity charOffset="2-11" id="DrugDDI.d270.s36.e0" origId="s36.p169" text="indinavir" type="drug"/></sentence><sentence id="DrugDDI.d270.s37" origId="s37" text="The optimal dose of indinavir, when given in combination with SUSTIVA, is not known."><entity charOffset="20-29" id="DrugDDI.d270.s37.e0" origId="s37.p171" text="indinavir" type="drug"/><entity charOffset="62-69" id="DrugDDI.d270.s37.e1" origId="s37.p175" text="SUSTIVA" type="drug"/><pair e1="DrugDDI.d270.s37.e0" e2="DrugDDI.d270.s37.e1" id="DrugDDI.d270.s37.p0" interaction="false"/><negationtags>&lt;xcope&gt; The optimal dose of indinavir, when given in combination with SUSTIVA, is &lt;cue&gt;not&lt;/cue&gt; known&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d270.s38" origId="s38" text="Increasing the indinavir dose to 1000 mg every 8 hours does not compensate for the increased indinavir metabolism due to SUSTIVA."><entity charOffset="15-24" id="DrugDDI.d270.s38.e0" origId="s38.p180" text="indinavir" type="drug"/><entity charOffset="93-102" id="DrugDDI.d270.s38.e1" origId="s38.p185" text="indinavir" type="drug"/><entity charOffset="121-128" id="DrugDDI.d270.s38.e2" origId="s38.p186" text="SUSTIVA" type="drug"/><pair e1="DrugDDI.d270.s38.e0" e2="DrugDDI.d270.s38.e1" id="DrugDDI.d270.s38.p0" interaction="false"/><pair e1="DrugDDI.d270.s38.e0" e2="DrugDDI.d270.s38.e2" id="DrugDDI.d270.s38.p1" interaction="false"/><pair e1="DrugDDI.d270.s38.e1" e2="DrugDDI.d270.s38.e2" id="DrugDDI.d270.s38.p2" interaction="false"/><negationtags>Increasing the indinavir dose to 1000 mg every 8 hours does &lt;xcope&gt;&lt;cue&gt;not&lt;/cue&gt; compensate for the increased indinavir metabolism due to SUSTIVA&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d270.s39" origId="s39" text="When indinavir at an increased dose (1000 mg every 8 hours) was given with SUSTIVA (600 mg once daily), the indinavir AUC and Cmin were decreased on average by 33-46% and 39-57%, respectively, compared to when indinavir (800 mg every 8 hours) was given alone."><entity charOffset="5-14" id="DrugDDI.d270.s39.e0" origId="s39.p188" text="indinavir" type="drug"/><entity charOffset="75-82" id="DrugDDI.d270.s39.e1" origId="s39.p195" text="SUSTIVA" type="drug"/><entity charOffset="108-117" id="DrugDDI.d270.s39.e2" origId="s39.p201" text="indinavir" type="drug"/><entity charOffset="210-219" id="DrugDDI.d270.s39.e3" origId="s39.p214" text="indinavir" type="drug"/><pair e1="DrugDDI.d270.s39.e0" e2="DrugDDI.d270.s39.e1" id="DrugDDI.d270.s39.p0" interaction="true"/><pair e1="DrugDDI.d270.s39.e0" e2="DrugDDI.d270.s39.e2" id="DrugDDI.d270.s39.p1" interaction="false"/><pair e1="DrugDDI.d270.s39.e0" e2="DrugDDI.d270.s39.e3" id="DrugDDI.d270.s39.p2" interaction="false"/><pair e1="DrugDDI.d270.s39.e1" e2="DrugDDI.d270.s39.e2" id="DrugDDI.d270.s39.p3" interaction="false"/><pair e1="DrugDDI.d270.s39.e1" e2="DrugDDI.d270.s39.e3" id="DrugDDI.d270.s39.p4" interaction="false"/><pair e1="DrugDDI.d270.s39.e2" e2="DrugDDI.d270.s39.e3" id="DrugDDI.d270.s39.p5" interaction="false"/></sentence><sentence id="DrugDDI.d270.s40" origId="s40" text="Lopinavir/ritonavir"><entity charOffset="0-9" id="DrugDDI.d270.s40.e0" origId="s40.p221" text="Lopinavir" type="drug"/><entity charOffset="10-19" id="DrugDDI.d270.s40.e1" origId="s40.p222" text="ritonavir" type="drug"/><pair e1="DrugDDI.d270.s40.e0" e2="DrugDDI.d270.s40.e1" id="DrugDDI.d270.s40.p0" interaction="false"/></sentence><sentence id="DrugDDI.d270.s41" origId="s41" text="??lopinavir concentration"><entity charOffset="2-11" id="DrugDDI.d270.s41.e0" origId="s41.p224" text="lopinavir" type="drug"/></sentence><sentence id="DrugDDI.d270.s42" origId="s42" text="A dose increase of lopinavir/ritonavir to 533/133 mg (4 capsules or 6.5 mL) twice daily taken with food is recommended when used in combination with SUSTIVA."><entity charOffset="19-28" id="DrugDDI.d270.s42.e0" origId="s42.p226" text="lopinavir" type="drug"/><entity charOffset="29-38" id="DrugDDI.d270.s42.e1" origId="s42.p227" text="ritonavir" type="drug"/><entity charOffset="149-156" id="DrugDDI.d270.s42.e2" origId="s42.p242" text="SUSTIVA" type="drug"/><pair e1="DrugDDI.d270.s42.e0" e2="DrugDDI.d270.s42.e1" id="DrugDDI.d270.s42.p0" interaction="false"/><pair e1="DrugDDI.d270.s42.e0" e2="DrugDDI.d270.s42.e2" id="DrugDDI.d270.s42.p1" interaction="false"/><pair e1="DrugDDI.d270.s42.e1" e2="DrugDDI.d270.s42.e2" id="DrugDDI.d270.s42.p2" interaction="false"/></sentence><sentence id="DrugDDI.d270.s43" origId="s43" text="Methadone"><entity charOffset="0-9" id="DrugDDI.d270.s43.e0" origId="s43.p243" text="Methadone" type="drug"/></sentence><sentence id="DrugDDI.d270.s44" origId="s44" text="??methadone concentration"><entity charOffset="2-11" id="DrugDDI.d270.s44.e0" origId="s44.p245" text="methadone" type="drug"/></sentence><sentence id="DrugDDI.d270.s45" origId="s45" text="Coadministration in HIV-infected individuals with a history of injection drug use resulted in decreased plasma levels of methadone and signs of opiate withdrawal."><entity charOffset="121-130" id="DrugDDI.d270.s45.e0" origId="s45.p252" text="methadone" type="drug"/><entity charOffset="144-150" id="DrugDDI.d270.s45.e1" origId="s45.p255" text="opiate" type="drug"/><pair e1="DrugDDI.d270.s45.e0" e2="DrugDDI.d270.s45.e1" id="DrugDDI.d270.s45.p0" interaction="true"/></sentence><sentence id="DrugDDI.d270.s46" origId="s46" text="Methadone dose was increased by a mean of 22% to alleviate withdrawal symptoms."/><sentence id="DrugDDI.d270.s47" origId="s47" text="Patients should be monitored for signs of withdrawal and their methadone dose increased as required to alleviate withdrawal symptoms."/><sentence id="DrugDDI.d270.s48" origId="s48" text="Ethinyl estradiol"><entity charOffset="0-17" id="DrugDDI.d270.s48.e0" origId="s48.p278" text="Ethinyl estradiol" type="drug"/></sentence><sentence id="DrugDDI.d270.s49" origId="s49" text="??ethinyl estradiol concentration"><entity charOffset="2-19" id="DrugDDI.d270.s49.e0" origId="s49.p280" text="ethinyl estradiol" type="drug"/></sentence><sentence id="DrugDDI.d270.s50" origId="s50" text="Plasma concentrations increased by SUSTIVA (efavirenz);"><entity charOffset="35-42" id="DrugDDI.d270.s50.e0" origId="s50.p283" text="SUSTIVA" type="drug"/><entity charOffset="44-53" id="DrugDDI.d270.s50.e1" origId="s50.p285" text="efavirenz" type="drug"/><pair e1="DrugDDI.d270.s50.e0" e2="DrugDDI.d270.s50.e1" id="DrugDDI.d270.s50.p0" interaction="false"/></sentence><sentence id="DrugDDI.d270.s51" origId="s51" text="clinical significance unknown."/><sentence id="DrugDDI.d270.s52" origId="s52" text="Because the potential interaction of efavirenz with oral contraceptives has not been fully characterized, a reliable method of barrier contraception should be used in addition to oral contraceptives."><entity charOffset="37-46" id="DrugDDI.d270.s52.e0" origId="s52.p292" text="efavirenz" type="drug"/><entity charOffset="52-71" id="DrugDDI.d270.s52.e1" origId="s52.p293" text="oral contraceptives" type="drug"/><entity charOffset="179-198" id="DrugDDI.d270.s52.e2" origId="s52.p306" text="oral contraceptives" type="drug"/><pair e1="DrugDDI.d270.s52.e0" e2="DrugDDI.d270.s52.e1" id="DrugDDI.d270.s52.p0" interaction="false"/><pair e1="DrugDDI.d270.s52.e0" e2="DrugDDI.d270.s52.e2" id="DrugDDI.d270.s52.p1" interaction="false"/><pair e1="DrugDDI.d270.s52.e1" e2="DrugDDI.d270.s52.e2" id="DrugDDI.d270.s52.p2" interaction="false"/><negationtags>Because the &lt;xcope&gt; potential interaction of efavirenz with oral contraceptives has &lt;cue&gt;not&lt;/cue&gt; been fully characterized&lt;/xcope&gt;, a reliable method of barrier contraception should be used in addition to oral contraceptives.</negationtags></sentence><sentence id="DrugDDI.d270.s53" origId="s53" text="Rifabutin"><entity charOffset="0-9" id="DrugDDI.d270.s53.e0" origId="s53.p307" text="Rifabutin" type="drug"/></sentence><sentence id="DrugDDI.d270.s54" origId="s54" text="??rifabutin concentration"><entity charOffset="2-11" id="DrugDDI.d270.s54.e0" origId="s54.p309" text="rifabutin" type="drug"/></sentence><sentence id="DrugDDI.d270.s55" origId="s55" text="Increase daily dose of rifabutin by 50%."><entity charOffset="23-32" id="DrugDDI.d270.s55.e0" origId="s55.p312" text="rifabutin" type="drug"/></sentence><sentence id="DrugDDI.d270.s56" origId="s56" text="Consider doubling the rifabutin dose in regimens where rifabutin is given 2 or 3 times a week."><entity charOffset="22-31" id="DrugDDI.d270.s56.e0" origId="s56.p316" text="rifabutin" type="drug"/><entity charOffset="55-64" id="DrugDDI.d270.s56.e1" origId="s56.p318" text="rifabutin" type="drug"/><pair e1="DrugDDI.d270.s56.e0" e2="DrugDDI.d270.s56.e1" id="DrugDDI.d270.s56.p0" interaction="false"/></sentence><sentence id="DrugDDI.d270.s57" origId="s57" text="Rifampin"><entity charOffset="0-8" id="DrugDDI.d270.s57.e0" origId="s57.p325" text="Rifampin" type="drug"/></sentence><sentence id="DrugDDI.d270.s58" origId="s58" text="??efavirenz concentration"><entity charOffset="2-11" id="DrugDDI.d270.s58.e0" origId="s58.p327" text="efavirenz" type="drug"/></sentence><sentence id="DrugDDI.d270.s59" origId="s59" text="Clinical significance of reduced efavirenz concentrations unknown."><entity charOffset="33-42" id="DrugDDI.d270.s59.e0" origId="s59.p329" text="efavirenz" type="drug"/></sentence><sentence id="DrugDDI.d270.s60" origId="s60" text="Ritonavir"><entity charOffset="0-9" id="DrugDDI.d270.s60.e0" origId="s60.p331" text="Ritonavir" type="drug"/></sentence><sentence id="DrugDDI.d270.s61" origId="s61" text="??ritonavir concentration"><entity charOffset="2-11" id="DrugDDI.d270.s61.e0" origId="s61.p333" text="ritonavir" type="drug"/></sentence><sentence id="DrugDDI.d270.s62" origId="s62" text="Combination was associated with a higher frequency of adverse clinical experiences (eg, dizziness, nausea, paresthesia) and laboratory abnormalities (elevated liver enzymes)."/><sentence id="DrugDDI.d270.s63" origId="s63" text="Monitoring of liver enzymes is recommended when SUSTIVA is used in combination with ritonavir."><entity charOffset="14-27" id="DrugDDI.d270.s63.e0" origId="s63.p351" text="liver enzymes" type="drug"/><entity charOffset="48-55" id="DrugDDI.d270.s63.e1" origId="s63.p355" text="SUSTIVA" type="drug"/><entity charOffset="84-93" id="DrugDDI.d270.s63.e2" origId="s63.p359" text="ritonavir" type="drug"/><pair e1="DrugDDI.d270.s63.e0" e2="DrugDDI.d270.s63.e1" id="DrugDDI.d270.s63.p0" interaction="false"/><pair e1="DrugDDI.d270.s63.e0" e2="DrugDDI.d270.s63.e2" id="DrugDDI.d270.s63.p1" interaction="false"/><pair e1="DrugDDI.d270.s63.e1" e2="DrugDDI.d270.s63.e2" id="DrugDDI.d270.s63.p2" interaction="true"/></sentence><sentence id="DrugDDI.d270.s64" origId="s64" text="??efavirenz concentration"><entity charOffset="2-11" id="DrugDDI.d270.s64.e0" origId="s64.p361" text="efavirenz" type="drug"/></sentence><sentence id="DrugDDI.d270.s65" origId="s65" text="Saquinavir"><entity charOffset="0-10" id="DrugDDI.d270.s65.e0" origId="s65.p362" text="Saquinavir" type="drug"/></sentence><sentence id="DrugDDI.d270.s66" origId="s66" text="??saquinavir concentration"><entity charOffset="2-12" id="DrugDDI.d270.s66.e0" origId="s66.p364" text="saquinavir" type="drug"/></sentence><sentence id="DrugDDI.d270.s67" origId="s67" text="Should not be used as sole protease inhibitor in combination with SUSTIVA."><entity charOffset="27-45" id="DrugDDI.d270.s67.e0" origId="s67.p369" text="protease inhibitor" type="drug"/><entity charOffset="66-73" id="DrugDDI.d270.s67.e1" origId="s67.p371" text="SUSTIVA" type="drug"/><pair e1="DrugDDI.d270.s67.e0" e2="DrugDDI.d270.s67.e1" id="DrugDDI.d270.s67.p0" interaction="true"/><negationtags>Should &lt;xcope&gt;&lt;cue&gt;not&lt;/cue&gt; be used as sole protease inhibitor in combination with SUSTIVA&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d270.s68" origId="s68" text="Sertraline"><entity charOffset="0-10" id="DrugDDI.d270.s68.e0" origId="s68.p372" text="Sertraline" type="drug"/></sentence><sentence id="DrugDDI.d270.s69" origId="s69" text="??sertraline concentration"><entity charOffset="2-12" id="DrugDDI.d270.s69.e0" origId="s69.p374" text="sertraline" type="drug"/></sentence><sentence id="DrugDDI.d270.s70" origId="s70" text="Increases in sertraline dose should be guided by clinical response."/><sentence id="DrugDDI.d270.s71" origId="s71" text="Other Potentially Clinically Significant Drug or Herbal Product Interactions With SUSTIVAb"><entity charOffset="41-45" id="DrugDDI.d270.s71.e0" origId="s71.p381" text="Drug" type="drug"/></sentence><sentence id="DrugDDI.d270.s72" origId="s72" text="Anticoagulants: Warfarin"><entity charOffset="0-14" id="DrugDDI.d270.s72.e0" origId="s72.p385" text="Anticoagulants" type="drug"/><entity charOffset="16-24" id="DrugDDI.d270.s72.e1" origId="s72.p387" text="Warfarin" type="drug"/><pair e1="DrugDDI.d270.s72.e0" e2="DrugDDI.d270.s72.e1" id="DrugDDI.d270.s72.p0" interaction="false"/></sentence><sentence id="DrugDDI.d270.s73" origId="s73" text="Plasma concentrations and effects potentially increased or decreased by SUSTIVA."><entity charOffset="72-79" id="DrugDDI.d270.s73.e0" origId="s73.p394" text="SUSTIVA" type="drug"/></sentence><sentence id="DrugDDI.d270.s74" origId="s74" text="Anticonvulsants: Phenytoin Phenobarbital Carbamazepine"><entity charOffset="0-15" id="DrugDDI.d270.s74.e0" origId="s74.p395" text="Anticonvulsants" type="drug"/><entity charOffset="27-40" id="DrugDDI.d270.s74.e1" origId="s74.p397" text="Phenobarbital" type="drug"/><pair e1="DrugDDI.d270.s74.e0" e2="DrugDDI.d270.s74.e1" id="DrugDDI.d270.s74.p0" interaction="false"/></sentence><sentence id="DrugDDI.d270.s75" origId="s75" text="Potential for reduction in anticonvulsant and/or efavirenz plasma levels;"><entity charOffset="27-41" id="DrugDDI.d270.s75.e0" origId="s75.p400" text="anticonvulsant" type="drug"/><entity charOffset="49-58" id="DrugDDI.d270.s75.e1" origId="s75.p402" text="efavirenz" type="drug"/><pair e1="DrugDDI.d270.s75.e0" e2="DrugDDI.d270.s75.e1" id="DrugDDI.d270.s75.p0" interaction="false"/></sentence><sentence id="DrugDDI.d270.s76" origId="s76" text="periodic monitoring of anticonvulsant plasma levels should be conducted."><entity charOffset="23-37" id="DrugDDI.d270.s76.e0" origId="s76.p405" text="anticonvulsant" type="drug"/></sentence><sentence id="DrugDDI.d270.s77" origId="s77" text="Antifungals: Itraconazole Ketoconazole"><entity charOffset="0-11" id="DrugDDI.d270.s77.e0" origId="s77.p409" text="Antifungals" type="drug"/><entity charOffset="13-25" id="DrugDDI.d270.s77.e1" origId="s77.p411" text="Itraconazole" type="drug"/><pair e1="DrugDDI.d270.s77.e0" e2="DrugDDI.d270.s77.e1" id="DrugDDI.d270.s77.p0" interaction="false"/></sentence><sentence id="DrugDDI.d270.s78" origId="s78" text="Drug interaction studies with SUSTIVA and these imidazole and triazole antifungals have not been conducted."><entity charOffset="30-37" id="DrugDDI.d270.s78.e0" origId="s78.p414" text="SUSTIVA" type="drug"/><entity charOffset="48-57" id="DrugDDI.d270.s78.e1" origId="s78.p416" text="imidazole" type="drug"/><entity charOffset="62-82" id="DrugDDI.d270.s78.e2" origId="s78.p418" text="triazole antifungals" type="drug"/><pair e1="DrugDDI.d270.s78.e0" e2="DrugDDI.d270.s78.e1" id="DrugDDI.d270.s78.p0" interaction="false"/><pair e1="DrugDDI.d270.s78.e0" e2="DrugDDI.d270.s78.e2" id="DrugDDI.d270.s78.p1" interaction="false"/><pair e1="DrugDDI.d270.s78.e1" e2="DrugDDI.d270.s78.e2" id="DrugDDI.d270.s78.p2" interaction="false"/><negationtags>&lt;xcope&gt;Drug interaction studies with SUSTIVA and these imidazole and triazole antifungals have &lt;cue&gt;not&lt;/cue&gt; been conducted&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d270.s79" origId="s79" text="SUSTIVA has the potential to decrease plasma concentrations of itraconazole and ketoconazole."><entity charOffset="0-7" id="DrugDDI.d270.s79.e0" origId="s79.p423" text="SUSTIVA" type="drug"/><entity charOffset="63-75" id="DrugDDI.d270.s79.e1" origId="s79.p428" text="itraconazole" type="drug"/><entity charOffset="80-92" id="DrugDDI.d270.s79.e2" origId="s79.p430" text="ketoconazole" type="drug"/><pair e1="DrugDDI.d270.s79.e0" e2="DrugDDI.d270.s79.e1" id="DrugDDI.d270.s79.p0" interaction="true"/><pair e1="DrugDDI.d270.s79.e0" e2="DrugDDI.d270.s79.e2" id="DrugDDI.d270.s79.p1" interaction="true"/><pair e1="DrugDDI.d270.s79.e1" e2="DrugDDI.d270.s79.e2" id="DrugDDI.d270.s79.p2" interaction="false"/></sentence><sentence id="DrugDDI.d270.s80" origId="s80" text="Anti-HIV protease inhibitors: Saquinavir/ritonavir combination"><entity charOffset="0-28" id="DrugDDI.d270.s80.e0" origId="s80.p431" text="anti-hiv protease inhibitors" type="drug"/><entity charOffset="30-40" id="DrugDDI.d270.s80.e1" origId="s80.p433" text="Saquinavir" type="drug"/><entity charOffset="41-50" id="DrugDDI.d270.s80.e2" origId="s80.p434" text="ritonavir" type="drug"/><pair e1="DrugDDI.d270.s80.e0" e2="DrugDDI.d270.s80.e1" id="DrugDDI.d270.s80.p0" interaction="false"/><pair e1="DrugDDI.d270.s80.e0" e2="DrugDDI.d270.s80.e2" id="DrugDDI.d270.s80.p1" interaction="false"/><pair e1="DrugDDI.d270.s80.e1" e2="DrugDDI.d270.s80.e2" id="DrugDDI.d270.s80.p2" interaction="false"/></sentence><sentence id="DrugDDI.d270.s81" origId="s81" text="No pharmacokinetic data are available."><negationtags>&lt;xcope&gt;&lt;cue&gt;No&lt;/cue&gt; pharmacokinetic data are available&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d270.s82" origId="s82" text="Amprenavir"><entity charOffset="0-10" id="DrugDDI.d270.s82.e0" origId="s82.p438" text="Amprenavir" type="drug"/></sentence><sentence id="DrugDDI.d270.s83" origId="s83" text="SUSTIVAhas the potential to decrease serum concentrations of amprenavir."><entity charOffset="61-71" id="DrugDDI.d270.s83.e0" origId="s83.p443" text="amprenavir" type="drug"/></sentence><sentence id="DrugDDI.d270.s84" origId="s84" text="Non-nucleoside reverse transcriptase inhibitors"><entity charOffset="0-47" id="DrugDDI.d270.s84.e0" origId="s84.p444" text="Non-nucleoside reverse transcriptase inhibitors" type="drug"/></sentence><sentence id="DrugDDI.d270.s85" origId="s85" text="No studies have been performed with other NNRTIs."><negationtags>&lt;xcope&gt;&lt;cue&gt;No&lt;/cue&gt; studies have been performed with other NNRTIs&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d270.s86" origId="s86" text="St. John?s wort (Hypericum perforatum)"><entity charOffset="17-37" id="DrugDDI.d270.s86.e0" origId="s86.p452" text="Hypericum perforatum" type="drug"/></sentence><sentence id="DrugDDI.d270.s87" origId="s87" text="Expected to substantially decrease plasma levels of efavirenz;has not been studied in combination with SUSTIVA."><entity charOffset="52-61" id="DrugDDI.d270.s87.e0" origId="s87.p458" text="efavirenz" type="drug"/><entity charOffset="103-110" id="DrugDDI.d270.s87.e1" origId="s87.p465" text="SUSTIVA" type="drug"/><pair e1="DrugDDI.d270.s87.e0" e2="DrugDDI.d270.s87.e1" id="DrugDDI.d270.s87.p0" interaction="false"/><negationtags>&lt;xcope&gt;Expected to substantially decrease plasma levels of efavirenz;has &lt;cue&gt;not&lt;/cue&gt; been studied in combination with SUSTIVA&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d270.s88" origId="s88" text="a See Tables 1 and 2."/><sentence id="DrugDDI.d270.s89" origId="s89" text="b This table is not all-inclusive."><negationtags>b This table is &lt;xcope&gt;&lt;cue&gt;not&lt;/cue&gt; all-inclusive&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d270.s90" origId="s90" text="Other Drugs: Based on the results of drug interaction studies, no dosage adjustment is recommended when SUSTIVA (efavirenz) is given with the following: aluminum/magnesium hydroxide antacids, azithromycin, cetirizine, famotidine, fluconazole, lamivudine, lorazepam, nelfinavir, paroxetine, and zidovudine."><entity charOffset="6-11" id="DrugDDI.d270.s90.e0" origId="s90.p475" text="Drugs" type="drug"/><entity charOffset="104-111" id="DrugDDI.d270.s90.e1" origId="s90.p484" text="SUSTIVA" type="drug"/><entity charOffset="113-122" id="DrugDDI.d270.s90.e2" origId="s90.p486" text="efavirenz" type="drug"/><entity charOffset="162-181" id="DrugDDI.d270.s90.e3" origId="s90.p493" text="magnesium hydroxide" type="drug"/><entity charOffset="192-204" id="DrugDDI.d270.s90.e4" origId="s90.p494" text="azithromycin" type="drug"/><entity charOffset="206-216" id="DrugDDI.d270.s90.e5" origId="s90.p495" text="cetirizine" type="drug"/><entity charOffset="218-228" id="DrugDDI.d270.s90.e6" origId="s90.p496" text="famotidine" type="drug"/><entity charOffset="230-241" id="DrugDDI.d270.s90.e7" origId="s90.p497" text="fluconazole" type="drug"/><entity charOffset="243-253" id="DrugDDI.d270.s90.e8" origId="s90.p498" text="lamivudine" type="drug"/><entity charOffset="255-264" id="DrugDDI.d270.s90.e9" origId="s90.p499" text="lorazepam" type="drug"/><entity charOffset="266-276" id="DrugDDI.d270.s90.e10" origId="s90.p500" text="nelfinavir" type="drug"/><entity charOffset="278-288" id="DrugDDI.d270.s90.e11" origId="s90.p501" text="paroxetine" type="drug"/><entity charOffset="294-304" id="DrugDDI.d270.s90.e12" origId="s90.p503" text="zidovudine" type="drug"/><pair e1="DrugDDI.d270.s90.e0" e2="DrugDDI.d270.s90.e1" id="DrugDDI.d270.s90.p0" interaction="false"/><pair e1="DrugDDI.d270.s90.e0" e2="DrugDDI.d270.s90.e2" id="DrugDDI.d270.s90.p1" interaction="false"/><pair e1="DrugDDI.d270.s90.e0" e2="DrugDDI.d270.s90.e3" id="DrugDDI.d270.s90.p2" interaction="false"/><pair e1="DrugDDI.d270.s90.e0" e2="DrugDDI.d270.s90.e4" id="DrugDDI.d270.s90.p3" interaction="false"/><pair e1="DrugDDI.d270.s90.e0" e2="DrugDDI.d270.s90.e5" id="DrugDDI.d270.s90.p4" interaction="false"/><pair e1="DrugDDI.d270.s90.e0" e2="DrugDDI.d270.s90.e6" id="DrugDDI.d270.s90.p5" interaction="false"/><pair e1="DrugDDI.d270.s90.e0" e2="DrugDDI.d270.s90.e7" id="DrugDDI.d270.s90.p6" interaction="false"/><pair e1="DrugDDI.d270.s90.e0" e2="DrugDDI.d270.s90.e8" id="DrugDDI.d270.s90.p7" interaction="false"/><pair e1="DrugDDI.d270.s90.e0" e2="DrugDDI.d270.s90.e9" id="DrugDDI.d270.s90.p8" interaction="false"/><pair e1="DrugDDI.d270.s90.e0" e2="DrugDDI.d270.s90.e10" id="DrugDDI.d270.s90.p9" interaction="false"/><pair e1="DrugDDI.d270.s90.e0" e2="DrugDDI.d270.s90.e11" id="DrugDDI.d270.s90.p10" interaction="false"/><pair e1="DrugDDI.d270.s90.e0" e2="DrugDDI.d270.s90.e12" id="DrugDDI.d270.s90.p11" interaction="false"/><pair e1="DrugDDI.d270.s90.e1" e2="DrugDDI.d270.s90.e2" id="DrugDDI.d270.s90.p12" interaction="false"/><pair e1="DrugDDI.d270.s90.e1" e2="DrugDDI.d270.s90.e3" id="DrugDDI.d270.s90.p13" interaction="false"/><pair e1="DrugDDI.d270.s90.e1" e2="DrugDDI.d270.s90.e4" id="DrugDDI.d270.s90.p14" interaction="false"/><pair e1="DrugDDI.d270.s90.e1" e2="DrugDDI.d270.s90.e5" id="DrugDDI.d270.s90.p15" interaction="false"/><pair e1="DrugDDI.d270.s90.e1" e2="DrugDDI.d270.s90.e6" id="DrugDDI.d270.s90.p16" interaction="false"/><pair e1="DrugDDI.d270.s90.e1" e2="DrugDDI.d270.s90.e7" id="DrugDDI.d270.s90.p17" interaction="false"/><pair e1="DrugDDI.d270.s90.e1" e2="DrugDDI.d270.s90.e8" id="DrugDDI.d270.s90.p18" interaction="false"/><pair e1="DrugDDI.d270.s90.e1" e2="DrugDDI.d270.s90.e9" id="DrugDDI.d270.s90.p19" interaction="false"/><pair e1="DrugDDI.d270.s90.e1" e2="DrugDDI.d270.s90.e10" id="DrugDDI.d270.s90.p20" interaction="false"/><pair e1="DrugDDI.d270.s90.e1" e2="DrugDDI.d270.s90.e11" id="DrugDDI.d270.s90.p21" interaction="false"/><pair e1="DrugDDI.d270.s90.e1" e2="DrugDDI.d270.s90.e12" id="DrugDDI.d270.s90.p22" interaction="false"/><pair e1="DrugDDI.d270.s90.e2" e2="DrugDDI.d270.s90.e3" id="DrugDDI.d270.s90.p23" interaction="false"/><pair e1="DrugDDI.d270.s90.e2" e2="DrugDDI.d270.s90.e4" id="DrugDDI.d270.s90.p24" interaction="false"/><pair e1="DrugDDI.d270.s90.e2" e2="DrugDDI.d270.s90.e5" id="DrugDDI.d270.s90.p25" interaction="false"/><pair e1="DrugDDI.d270.s90.e2" e2="DrugDDI.d270.s90.e6" id="DrugDDI.d270.s90.p26" interaction="false"/><pair e1="DrugDDI.d270.s90.e2" e2="DrugDDI.d270.s90.e7" id="DrugDDI.d270.s90.p27" interaction="false"/><pair e1="DrugDDI.d270.s90.e2" e2="DrugDDI.d270.s90.e8" id="DrugDDI.d270.s90.p28" interaction="false"/><pair e1="DrugDDI.d270.s90.e2" e2="DrugDDI.d270.s90.e9" id="DrugDDI.d270.s90.p29" interaction="false"/><pair e1="DrugDDI.d270.s90.e2" e2="DrugDDI.d270.s90.e10" id="DrugDDI.d270.s90.p30" interaction="false"/><pair e1="DrugDDI.d270.s90.e2" e2="DrugDDI.d270.s90.e11" id="DrugDDI.d270.s90.p31" interaction="false"/><pair e1="DrugDDI.d270.s90.e2" e2="DrugDDI.d270.s90.e12" id="DrugDDI.d270.s90.p32" interaction="false"/><pair e1="DrugDDI.d270.s90.e3" e2="DrugDDI.d270.s90.e4" id="DrugDDI.d270.s90.p33" interaction="false"/><pair e1="DrugDDI.d270.s90.e3" e2="DrugDDI.d270.s90.e5" id="DrugDDI.d270.s90.p34" interaction="false"/><pair e1="DrugDDI.d270.s90.e3" e2="DrugDDI.d270.s90.e6" id="DrugDDI.d270.s90.p35" interaction="false"/><pair e1="DrugDDI.d270.s90.e3" e2="DrugDDI.d270.s90.e7" id="DrugDDI.d270.s90.p36" interaction="false"/><pair e1="DrugDDI.d270.s90.e3" e2="DrugDDI.d270.s90.e8" id="DrugDDI.d270.s90.p37" interaction="false"/><pair e1="DrugDDI.d270.s90.e3" e2="DrugDDI.d270.s90.e9" id="DrugDDI.d270.s90.p38" interaction="false"/><pair e1="DrugDDI.d270.s90.e3" e2="DrugDDI.d270.s90.e10" id="DrugDDI.d270.s90.p39" interaction="false"/><pair e1="DrugDDI.d270.s90.e3" e2="DrugDDI.d270.s90.e11" id="DrugDDI.d270.s90.p40" interaction="false"/><pair e1="DrugDDI.d270.s90.e3" e2="DrugDDI.d270.s90.e12" id="DrugDDI.d270.s90.p41" interaction="false"/><pair e1="DrugDDI.d270.s90.e4" e2="DrugDDI.d270.s90.e5" id="DrugDDI.d270.s90.p42" interaction="false"/><pair e1="DrugDDI.d270.s90.e4" e2="DrugDDI.d270.s90.e6" id="DrugDDI.d270.s90.p43" interaction="false"/><pair e1="DrugDDI.d270.s90.e4" e2="DrugDDI.d270.s90.e7" id="DrugDDI.d270.s90.p44" interaction="false"/><pair e1="DrugDDI.d270.s90.e4" e2="DrugDDI.d270.s90.e8" id="DrugDDI.d270.s90.p45" interaction="false"/><pair e1="DrugDDI.d270.s90.e4" e2="DrugDDI.d270.s90.e9" id="DrugDDI.d270.s90.p46" interaction="false"/><pair e1="DrugDDI.d270.s90.e4" e2="DrugDDI.d270.s90.e10" id="DrugDDI.d270.s90.p47" interaction="false"/><pair e1="DrugDDI.d270.s90.e4" e2="DrugDDI.d270.s90.e11" id="DrugDDI.d270.s90.p48" interaction="false"/><pair e1="DrugDDI.d270.s90.e4" e2="DrugDDI.d270.s90.e12" id="DrugDDI.d270.s90.p49" interaction="false"/><pair e1="DrugDDI.d270.s90.e5" e2="DrugDDI.d270.s90.e6" id="DrugDDI.d270.s90.p50" interaction="false"/><pair e1="DrugDDI.d270.s90.e5" e2="DrugDDI.d270.s90.e7" id="DrugDDI.d270.s90.p51" interaction="false"/><pair e1="DrugDDI.d270.s90.e5" e2="DrugDDI.d270.s90.e8" id="DrugDDI.d270.s90.p52" interaction="false"/><pair e1="DrugDDI.d270.s90.e5" e2="DrugDDI.d270.s90.e9" id="DrugDDI.d270.s90.p53" interaction="false"/><pair e1="DrugDDI.d270.s90.e5" e2="DrugDDI.d270.s90.e10" id="DrugDDI.d270.s90.p54" interaction="false"/><pair e1="DrugDDI.d270.s90.e5" e2="DrugDDI.d270.s90.e11" id="DrugDDI.d270.s90.p55" interaction="false"/><pair e1="DrugDDI.d270.s90.e5" e2="DrugDDI.d270.s90.e12" id="DrugDDI.d270.s90.p56" interaction="false"/><pair e1="DrugDDI.d270.s90.e6" e2="DrugDDI.d270.s90.e7" id="DrugDDI.d270.s90.p57" interaction="false"/><pair e1="DrugDDI.d270.s90.e6" e2="DrugDDI.d270.s90.e8" id="DrugDDI.d270.s90.p58" interaction="false"/><pair e1="DrugDDI.d270.s90.e6" e2="DrugDDI.d270.s90.e9" id="DrugDDI.d270.s90.p59" interaction="false"/><pair e1="DrugDDI.d270.s90.e6" e2="DrugDDI.d270.s90.e10" id="DrugDDI.d270.s90.p60" interaction="false"/><pair e1="DrugDDI.d270.s90.e6" e2="DrugDDI.d270.s90.e11" id="DrugDDI.d270.s90.p61" interaction="false"/><pair e1="DrugDDI.d270.s90.e6" e2="DrugDDI.d270.s90.e12" id="DrugDDI.d270.s90.p62" interaction="false"/><pair e1="DrugDDI.d270.s90.e7" e2="DrugDDI.d270.s90.e8" id="DrugDDI.d270.s90.p63" interaction="false"/><pair e1="DrugDDI.d270.s90.e7" e2="DrugDDI.d270.s90.e9" id="DrugDDI.d270.s90.p64" interaction="false"/><pair e1="DrugDDI.d270.s90.e7" e2="DrugDDI.d270.s90.e10" id="DrugDDI.d270.s90.p65" interaction="false"/><pair e1="DrugDDI.d270.s90.e7" e2="DrugDDI.d270.s90.e11" id="DrugDDI.d270.s90.p66" interaction="false"/><pair e1="DrugDDI.d270.s90.e7" e2="DrugDDI.d270.s90.e12" id="DrugDDI.d270.s90.p67" interaction="false"/><pair e1="DrugDDI.d270.s90.e8" e2="DrugDDI.d270.s90.e9" id="DrugDDI.d270.s90.p68" interaction="false"/><pair e1="DrugDDI.d270.s90.e8" e2="DrugDDI.d270.s90.e10" id="DrugDDI.d270.s90.p69" interaction="false"/><pair e1="DrugDDI.d270.s90.e8" e2="DrugDDI.d270.s90.e11" id="DrugDDI.d270.s90.p70" interaction="false"/><pair e1="DrugDDI.d270.s90.e8" e2="DrugDDI.d270.s90.e12" id="DrugDDI.d270.s90.p71" interaction="false"/><pair e1="DrugDDI.d270.s90.e9" e2="DrugDDI.d270.s90.e10" id="DrugDDI.d270.s90.p72" interaction="false"/><pair e1="DrugDDI.d270.s90.e9" e2="DrugDDI.d270.s90.e11" id="DrugDDI.d270.s90.p73" interaction="false"/><pair e1="DrugDDI.d270.s90.e9" e2="DrugDDI.d270.s90.e12" id="DrugDDI.d270.s90.p74" interaction="false"/><pair e1="DrugDDI.d270.s90.e10" e2="DrugDDI.d270.s90.e11" id="DrugDDI.d270.s90.p75" interaction="false"/><pair e1="DrugDDI.d270.s90.e10" e2="DrugDDI.d270.s90.e12" id="DrugDDI.d270.s90.p76" interaction="false"/><pair e1="DrugDDI.d270.s90.e11" e2="DrugDDI.d270.s90.e12" id="DrugDDI.d270.s90.p77" interaction="false"/><negationtags>Other Drugs: &lt;xcope&gt; Based on the results of drug interaction studies, &lt;cue&gt;no&lt;/cue&gt; dosage adjustment is recommended &lt;/xcope&gt; when SUSTIVA (efavirenz) is given  with the following: aluminum/magnesium hydroxide antacids, azithromycin, cetirizine, famotidine, fluconazole, lamivudine, lorazepam, nelfinavir, paroxetine, and zidovudine.</negationtags></sentence><sentence id="DrugDDI.d270.s91" origId="s91" text="Specific drug interaction studies have not been performed with SUSTIVA and NRTIs other than lamivudine and zidovudine."><entity charOffset="63-70" id="DrugDDI.d270.s91.e0" origId="s91.p509" text="SUSTIVA" type="drug"/><entity charOffset="92-102" id="DrugDDI.d270.s91.e1" origId="s91.p512" text="lamivudine" type="drug"/><entity charOffset="107-117" id="DrugDDI.d270.s91.e2" origId="s91.p514" text="zidovudine" type="drug"/><pair e1="DrugDDI.d270.s91.e0" e2="DrugDDI.d270.s91.e1" id="DrugDDI.d270.s91.p0" interaction="false"/><pair e1="DrugDDI.d270.s91.e0" e2="DrugDDI.d270.s91.e2" id="DrugDDI.d270.s91.p1" interaction="false"/><pair e1="DrugDDI.d270.s91.e1" e2="DrugDDI.d270.s91.e2" id="DrugDDI.d270.s91.p2" interaction="false"/><negationtags>&lt;xcope&gt;Specific drug interaction studies have &lt;cue&gt;not&lt;/cue&gt; been performed with SUSTIVA and NRTIs other than lamivudine and zidovudine&lt;/xcope&gt;.</negationtags></sentence><sentence id="DrugDDI.d270.s92" origId="s92" text="Clinically significant interactions would not be expected since the NRTIs are metabolized via a different route than efavirenz and would be unlikely to compete for the same metabolic enzymes and elimination pathways."><entity charOffset="117-126" id="DrugDDI.d270.s92.e0" origId="s92.p525" text="efavirenz" type="drug"/><entity charOffset="152-159" id="DrugDDI.d270.s92.e1" origId="s92.p530" text="compete" type="drug"/><pair e1="DrugDDI.d270.s92.e0" e2="DrugDDI.d270.s92.e1" id="DrugDDI.d270.s92.p0" interaction="false"/><negationtags>&lt;xcope&gt; Clinically significant interactions would &lt;cue&gt;not&lt;/cue&gt; be expected&lt;/xcope&gt; since the NRTIs are metabolized via a different route than efavirenz and would be unlikely to compete for the same metabolic enzymes and elimination pathways.</negationtags></sentence></document>